DENA SEIFERT: Open Payments
NPI 1447674668 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 21 payments from 13 companies in 2025. Trend: 2023 $255 · 2024 $584 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 1 | $112 |
| Boston Scientific Corporation | 1 | $101 |
| Vanda Pharmaceuticals Inc. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| JAZZ PHARMACEUTICALS INC. | 2 | $61 |
| ABBVIE INC. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
Products named: XPHOZAH 30 MG, General - Pain Management, HETLIOZ, INGREZZA, XYWAV, VRAYLAR, CAPLYTA, BOTOX.
Industry payments across IN — which companies pay providers there.
